(PR-inside.com) 
More...

Clinical Trial Also Underway in U.S., Canada and Other Geographies
DUBLIN - August 21, 2017 - Medtronic plc (NYSE: MDT) announced it has received CE () Mark for the Attain Stability(TM) Quad MRI SureScan(TM) left heart lead. Paired with Medtronic quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead features novel, active-fixation technology that is designed for precise lead placement and stability. In the United States, the Attain Stability Quad lead is under evaluation in a clinical .. More...